Baldwin Insurance Group, Inc. (BWIN)
(Real Time Quote from BATS)
$41.32 USD
-0.28 (-0.67%)
Updated Jul 24, 2024 11:32 AM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
The Baldwin Insurance Group (BWIN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$39.43 | $46.00 | $28.00 | -5.22% |
Price Target
Based on short-term price targets offered by seven analysts, the average price target for The Baldwin Insurance Group comes to $39.43. The forecasts range from a low of $28.00 to a high of $46.00. The average price target represents a decline of 5.22% from the last closing price of $41.60.
Analyst Price Targets (7 )
Broker Rating
The Baldwin Insurance Group currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by nine brokerage firms. The current ABR compares to an ABR of 1.88 a month ago based on eight recommendations.
Of the nine recommendations deriving the current ABR, four are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 44.44% and 11.11% of all recommendations. A month ago, Strong Buy made up 50%, while Buy represented 12.5%.
Broker Rating Breakdown
![Broker Rating Visualization](https://widget3.zacks.com/images/charts/bar/brokerage/bar/BWIN.png)
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 4 | 4 | 4 | 4 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 4 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 1.88 | 1.88 | 1.88 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/9/2024 | Dowling & Partners | Anthony Mottolese | Not Available | Hold |
6/28/2024 | Keefe Bruyette & Woods | Meyer Shields | Moderate Buy | Moderate Buy |
5/22/2024 | Raymond James | Charles G Peters | Strong Buy | Strong Buy |
5/14/2024 | UBS | Brian R Meredith | Strong Buy | Strong Buy |
5/7/2024 | Not Identified | Not Identified | Hold | Hold |
5/7/2024 | William Blair | Adam Klauber | Hold | Hold |
4/11/2024 | Wells Fargo Securities | Elyse Greenspan | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 9 |
Average Target Price | $39.43 |
LT Growth Rate | 33.80% |
Industry | Insurance - Life Insurance |
Industry Rank by ABR | 104 of 252 |
Current Quarter EPS Est: | 0.33 |